{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:22:01Z","timestamp":1794370921699,"version":"4.9.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s13555-023-00919-x","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T15:02:41Z","timestamp":1680534161000},"page":"1157-1169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4748-3818","authenticated-orcid":false,"given":"Zari","family":"Shadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"919_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2165\/00128071-200001030-00002","volume":"1","author":"C Bolduc","year":"2000","unstructured":"Bolduc C, Shapiro J. Management of androgenetic alopecia. Am J Clin Dermatol. 2000;1:151\u20138. https:\/\/doi.org\/10.2165\/00128071-200001030-00002.","journal-title":"Am J Clin Dermatol"},{"key":"919_CR2","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1056\/NEJM199909233411307","volume":"341","author":"VH Price","year":"1999","unstructured":"Price VH. Treatment of hair loss. New Engl J Med. 1999;341:964\u201373.","journal-title":"New Engl J Med"},{"key":"919_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/archderm.1985.01660020055017","volume":"121","author":"RL de Villez","year":"1985","unstructured":"de Villez RL. Topical minoxidil therapy in hereditary androgenetic alopecia. Arch Dermatol. 1985;121:197\u2013202.","journal-title":"Arch Dermatol"},{"key":"919_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0190-9622(86)70138-2","volume":"15","author":"EA Olsen","year":"1986","unstructured":"Olsen EA, DeLong ER, Weiner MS. Dose\u2013response study of topical minoxidil in male pattern baldness. J Am Acad Dermatol. 1986;15:30\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"919_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0738-081X(88)90087-9","volume":"6","author":"HI Katz","year":"1988","unstructured":"Katz HI. Topical minoxidil: review of efficacy. Clin Dermatol. 1988;6:195\u20139.","journal-title":"Clin Dermatol"},{"key":"919_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jaad.2007.04.012","volume":"57","author":"EA Olsen","year":"2007","unstructured":"Olsen EA, Whiting D, Bergfeld W, Miller J, Hordinsky M, Wanser R, et\u00a0al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007;57:767\u201374.","journal-title":"J Am Acad Dermatol"},{"key":"919_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1067\/mjd.2002.119104","volume":"46","author":"ES Friedman","year":"2002","unstructured":"Friedman ES, Friedman PM, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol. 2002;46:309\u201312.","journal-title":"J Am Acad Dermatol"},{"key":"919_CR8","first-page":"37","volume":"17","author":"R Tsuboi","year":"2007","unstructured":"Tsuboi R, Tanaka T, Nishikawa T, Ueki R, Yamada H, Katsuoka K, et\u00a0al. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women. Eur J Dermatol. 2007;17:37\u201344.","journal-title":"Eur J Dermatol"},{"key":"919_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/187221312800166859","volume":"6","author":"A Rossi","year":"2012","unstructured":"Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012;6:130\u20136.","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"919_CR10","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jaad.2010.09.724","volume":"65","author":"U Blume-Peytavi","year":"2011","unstructured":"Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia BN. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol. 2011;65:1126-1134.e2.","journal-title":"J Am Acad Dermatol"},{"key":"919_CR11","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.18632\/oncotarget.1886","volume":"5","author":"C-L Hsu","year":"2014","unstructured":"Hsu C-L, Liu J-S, Lin A-C, Yang C-H, Chung W-H, Wu W-G. Minoxidil may suppress androgen receptor-related functions. Oncotarget. 2014;5:2187\u201397.","journal-title":"Oncotarget"},{"key":"919_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.mce.2017.09.009","volume":"465","author":"JM Ceruti","year":"2018","unstructured":"Ceruti JM, Leir\u00f3s GJ, Bala\u00f1\u00e1 ME. Androgens and androgen receptor action in skin and hair follicles. Mol Cell Endocrinol. 2018;465:122\u201333. https:\/\/doi.org\/10.1016\/j.mce.2017.09.009.","journal-title":"Mol Cell Endocrinol"},{"key":"919_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1046\/j.1365-2133.1998.02115.x","volume":"138","author":"S Lachgar","year":"1998","unstructured":"Lachgar S, Charveron M, Gall Y, Bonafe JL. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol. 1998;138:407\u201311.","journal-title":"Br J Dermatol"},{"key":"919_CR14","volume-title":"Hypertrichosis","author":"D Saleh","year":"2022","unstructured":"Saleh D, Yarrarapu SN, Cook C. Hypertrichosis. Island: StatPearls Publishing; 2022."},{"key":"919_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5001\/omj.2011.38","volume":"26","author":"B Jimmy","year":"2011","unstructured":"Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26:155\u20139.","journal-title":"Oman Med J"},{"issue":"10","key":"919_CR16","first-page":"1140","volume":"21","author":"D Nussbaum","year":"2022","unstructured":"Nussbaum D, Murphy E, Nelson K, Gonzalez-Lopez A, Qureshi A, Schwartz J, Friedman A. A survey of patient attitudes towards topical minoxidil in the treatment of hair loss. J Drugs Dermatol JDD. 2022;21(10):1140\u20132.","journal-title":"J Drugs Dermatol JDD"},{"key":"919_CR17","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1097\/DSS.0000000000001894","volume":"45","author":"AK Gupta","year":"2019","unstructured":"Gupta AK, Cole J, Deutsch DP, Everts PA, Niedbalski RP, Panchaprateep R, et\u00a0al. Platelet-rich plasma as a treatment for androgenetic alopecia. Dermatol Surg. 2019;45:1262\u201373.","journal-title":"Dermatol Surg"},{"key":"919_CR18","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1517\/14656561003752730","volume":"11","author":"D Rathnayake","year":"2010","unstructured":"Rathnayake D, Sinclair R. Male androgenetic alopecia. Expert Opin Pharmacother. 2010;11:1295\u2013304. https:\/\/doi.org\/10.1517\/14656561003752730.","journal-title":"Expert Opin Pharmacother"},{"key":"919_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.0909-752X.2006.00196.x","volume":"12","author":"T RezanEkmekci","year":"2006","unstructured":"RezanEkmekci T, Koslu A. Phototrichogram findings in women with androgenetic alopecia. Skin Res Technol. 2006;12:309\u201312. https:\/\/doi.org\/10.1111\/j.0909-752X.2006.00196.x.","journal-title":"Skin Res Technol"},{"key":"919_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1468-3083.2009.03411.x","volume":"24","author":"T Ekmekci","year":"2010","unstructured":"Ekmekci T, Sakiz D, Koslu A. Occipital involvement in female pattern hair loss: histopathological evidences. J Eur Acad Dermatol Venereol. 2010;24:299\u2013301. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03411.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"919_CR21","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2147\/CCID.S334807","volume":"14","author":"S Zari","year":"2021","unstructured":"Zari S. Short-term efficacy of autologous cellular micrografts in male and female androgenetic alopecia: a retrospective cohort study. Clin Cosmet Investig Dermatol. 2021;14:1725\u201336.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"919_CR22","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1002\/jcp.29335","volume":"235","author":"RG Ruiz","year":"2020","unstructured":"Ruiz RG, Rosell JMC, Ceccarelli G, de Sio C, de Angelis GC, Pinto H, et\u00a0al. Progenitor-cell-enriched micrografts as a novel option for the management of androgenetic alopecia. J Cell Physiol. 2020;235:4587\u201393. https:\/\/doi.org\/10.1002\/jcp.29335.","journal-title":"J Cell Physiol"},{"key":"919_CR23","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1080\/09546634.2022.2109567","volume":"33","author":"AK Gupta","year":"2022","unstructured":"Gupta AK, Talukder M, Williams G. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. J Dermatol Treat. 2022;33:2946\u201362. https:\/\/doi.org\/10.1080\/09546634.2022.2109567.","journal-title":"J Dermatol Treat"},{"key":"919_CR24","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1080\/09546634.2021.1959506","volume":"33","author":"AK Gupta","year":"2022","unstructured":"Gupta AK, Venkataraman M, Talukder M, Bamimore MA. Finasteride for hair loss: a review. J Dermatol Treat. 2022;33:1938\u201346. https:\/\/doi.org\/10.1080\/09546634.2021.1959506.","journal-title":"J Dermatol Treat"},{"key":"919_CR25","first-page":"189","volume":"2","author":"QQ Dinh","year":"2007","unstructured":"Dinh QQ, Sinclair R. Female pattern hair loss: current treatment concepts. Clin Interv Aging. 2007;2:189\u201399.","journal-title":"Clin Interv Aging"},{"key":"919_CR26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3892\/etm.2013.1126","volume":"6","author":"X-S Zhuang","year":"2013","unstructured":"Zhuang X-S, Zheng Y-Y, Xu J-J, Fan W-X. Quality of life in women with female pattern hair loss and the impact of topical minoxidil treatment on quality of life in these patients. Exp Ther Med. 2013;6:542\u20136. https:\/\/doi.org\/10.3892\/etm.2013.1126.","journal-title":"Exp Ther Med"},{"key":"919_CR27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/0190-9622(93)70223-G","volume":"29","author":"TF Cash","year":"1993","unstructured":"Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol. 1993;29:568\u201375.","journal-title":"J Am Acad Dermatol"},{"key":"919_CR28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/her\/cyu023","volume":"29","author":"JM Polinski","year":"2014","unstructured":"Polinski JM, Kesselheim AS, Frolkis JP, Wescott P, Allen-Coleman C, Fischer MA. A matter of trust: patient barriers to primary medication adherence. Health Educ Res. 2014;29:755\u201363.","journal-title":"Health Educ Res"},{"key":"919_CR29","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3109\/03639045.2014.900078","volume":"41","author":"A Lopedota","year":"2015","unstructured":"Lopedota A, Cutrignelli A, Denora N, Laquintana V, Lopalco A, Selva S, et\u00a0al. New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl-\u03b2-cyclodextrin complex as promising tools for alopecia treatment. Drug Dev Ind Pharm. 2015;41:728\u201336.","journal-title":"Drug Dev Ind Pharm"},{"key":"919_CR30","doi-asserted-by":"publisher","first-page":"341","DOI":"10.23736\/S0392-0488.20.06554-2","volume":"155","author":"M Barbareschi","year":"2020","unstructured":"Barbareschi M, Vescovi V, Starace M, Piraccini BM, Milani M. Propylene glycol free 5% minoxidil lotion formulation: cosmetic acceptability, local tolerability, clinical efficacy and in-vitro skin absorption evaluations. G Ital Dermatol Venereol. 2020;155:341\u20135.","journal-title":"G Ital Dermatol Venereol"},{"key":"919_CR31","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4103\/0019-5154.84714","volume":"56","author":"T Purnak","year":"2011","unstructured":"Purnak T, Senel E, Sahin C. Liquid formulation of minoxidil versus its foam formulation. Indian J Dermatol. 2011;56:462.","journal-title":"Indian J Dermatol"},{"key":"919_CR32","first-page":"44","volume":"6","author":"G Gary","year":"2013","unstructured":"Gary G. Optimizing treatment approaches in seborrheic dermatitis. J Clin Aesthet Dermatol. 2013;6:44\u20139.","journal-title":"J Clin Aesthet Dermatol"},{"key":"919_CR33","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.jaad.2021.02.054","volume":"84","author":"S Va\u00f1\u00f3-Galv\u00e1n","year":"2021","unstructured":"Va\u00f1\u00f3-Galv\u00e1n S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones \u00d3M, Saceda-Corralo D, Rodrigues-Barata R, et\u00a0al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84:1644\u201351.","journal-title":"J Am Acad Dermatol"},{"key":"919_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jaad.2020.04.027","volume":"86","author":"A Therianou","year":"2022","unstructured":"Therianou A, Vincenzi C, Tosti A. How safe is prescribing oral minoxidil in patients allergic to topical minoxidil? J Am Acad Dermatol. 2022;86:429\u201331.","journal-title":"J Am Acad Dermatol"},{"key":"919_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/dth.12111","volume":"27","author":"A Goren","year":"2014","unstructured":"Goren A, Castano JA, McCoy J, Bermudez F, Lotti T. Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia. Dermatol Ther. 2014;27:171\u20133.","journal-title":"Dermatol Ther"},{"key":"919_CR36","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/dth.12130","volume":"27","author":"J Roberts","year":"2014","unstructured":"Roberts J, Desai N, McCoy J, Goren A. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia. Dermatol Ther. 2014;27:252\u20134.","journal-title":"Dermatol Ther"},{"key":"919_CR37","doi-asserted-by":"publisher","first-page":"472","DOI":"10.5114\/ada.2020.99947","volume":"39","author":"K Pietrauszka","year":"2022","unstructured":"Pietrauszka K, Bergler-Czop B. Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review. Postepy Dermatol Alergol. 2022;39:472\u20138.","journal-title":"Postepy Dermatol Alergol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00919-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-023-00919-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00919-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T13:07:35Z","timestamp":1682860055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-023-00919-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["919"],"URL":"https:\/\/doi.org\/10.1007\/s13555-023-00919-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"21 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}